Yep you are correct ymav4294. The data on progression free survival(PFS) is the key to efficacy of CVac. The ongoing CAN003 data for the 63patients and the Can004 will tell us the extent of efficacy. The ICS as you say came out great as was expected but in a formal way supported by specific data that will be accepted by the scientific world and the authorities in drug development.
cheers
- Forums
- ASX - By Stock
- Ann: CAN-003 INTERIM ANALYSIS PRESENTATION
Yep you are correct ymav4294. The data on progression free...
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMM (ASX) to my watchlist
(20min delay)
|
|||||
Last
34.0¢ |
Change
-0.005(1.45%) |
Mkt cap ! $493.8M |
Open | High | Low | Value | Volume |
34.0¢ | 34.0¢ | 32.5¢ | $1.317M | 3.935M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 73996 | 33.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
34.0¢ | 836970 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
10 | 67679 | 0.325 |
11 | 193888 | 0.320 |
1 | 25000 | 0.315 |
2 | 35400 | 0.310 |
5 | 103336 | 0.305 |
Price($) | Vol. | No. |
---|---|---|
0.340 | 674262 | 1 |
0.345 | 179754 | 4 |
0.350 | 527571 | 5 |
0.355 | 30000 | 1 |
0.360 | 51000 | 2 |
Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
Featured News
IMM (ASX) Chart |